Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0.02
Key Takeaways
Risk factor
Considerable default risk
Profitability factor
Very low or no dividends
Data is available to registered users only
Data is available to registered users only
About
NovelStem International Corp. focuses on developing and commercialization of diagnostic technology for cancer treatments and the potential to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was founded in 1993 and is headquartered in Boca Raton,...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is neutral on EV/EBITDA.
Data is available to registered users only
Buy
Sell